ELPAMOTIDE

UNII:	S68632MB2G
Type:	INGREDIENT SUBSTANCE
Formula:	C₄₇H₇₆N₁₆O₁₃
Preferred Substance Name:	ELPAMOTIDE
InChIKey:	ZAJHBCDPAUKEPU-GIKXZWSFSA-N
GSRS Full Record:	S68632MB2G i

673478-49-4
(2S,3S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoic acid
ELPAMOTIDE [JAN]
Elpamotide [WHO-DD]
L-ARGINYL-L-PHENYLALANYL-L-VALYL-L-PROLYL-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-L-ARGINYL-L-ISOLEUCINE HUMAN SOLUBLE (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR) VEGFR2-(169-177)-PEPTIDE
L-ISOLEUCINE, L-ARGINYL-L-PHENYLALANYL-L-VALYL-L-PROLYL-L-.ALPHA.-ASPARTYLGLYCYL-L-ASPARAGINYL-L-ARGINYL-
VEGFR2-169
VEGFR2-169 PEPTIDE VACCINE
elpamotide [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ELPAMOTIDE

Synonyms and Mappings

Resources